Glycosylation might provide endothelial zip codes for organ-specific leukocyte traffic into inflammatory sites

American Journal of Pathology

Volumn 161, Issue 2, 2002, Pages 543-550

  Renkonen, Jutta ^a,c   Tynninen, Olli ^a,c   Häyry, Pekka ^a,b   Paavonen, Timo ^a,c   Renkonen, Risto ^a,b,c  

^a UNIVERSITY OF HELSINKI   (Finland)

^b UNIVERSITY OF HELSINKI   (Finland)

^c HELSINKI UNIVERSITY CENTRAL HOSPITAL   (Finland)

Author keywords

[No Author keywords available]

Indexed keywords

CELL MEMBRANE MARKER; GLYCAN DERIVATIVE; L SELECTIN; LACTOSAMINE; LIGAND; MONOCLONAL ANTIBODY; PROTEIN 2F3; PROTEIN HECA 452; PROTEIN SLEX; SIALIC ACID DERIVATIVE; UNCLASSIFIED DRUG; ZIP CODE GLYCAN;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ANTIBODY PRODUCTION; ANTIBODY SPECIFICITY; ARTICLE; CONTROLLED STUDY; ENDOTHELIUM CELL; EXTRAVASATION; HISTOPATHOLOGY; HUMAN; IMMUNOHISTOCHEMISTRY; INFLAMMATION; INHIBITION KINETICS; LEUKOCYTE; LIGAND BINDING; LYMPHOCYTIC INFILTRATION; MOUSE; MYOCARDITIS; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PSORIASIS; THYROIDITIS; TISSUE SPECIFICITY; ULCERATIVE COLITIS; VASCULITIS; VENULE;

EID: 0036966385     PISSN: 00029440     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0002-9440(10)64210-1     Document Type: Article

References (39)

1. Rosen SD: Endothelial ligands for L-selectin. From lymphocyte recirculation to allograft rejection. Am J Pathol 1999, 155:1013-1020
2. Toppila S, Paavonen P, Nieminen M, Hayry P, Renkonen R: Endothelial L-selectin ligands are likely to recruit lymphocytes into rejecting human heart transplants. Am J Pathol 1999, 155:1303-1310
3. Toppila S, Paavonen T, Laitinen A, Laitinen L, Renkonen R: Endothelial L-selectin ligands in bronchial asthma but not in other chronic inflammatory lung diseases. Am J Respir Cell Mol Biol 2000, 23:492-498
4. Kirveskari J, Paavonen T, Hayry P, Renkonen R: De novo induction of endothelial L-selectin ligands during kidney allograft rejection. J Am Soc Nephrol 2000, 11:2358-2365
5. Butcher EC, Williams M, Youngman K, Rott L, Briskin M: Lymphocyte trafficking and regional immunity. Adv Immunol 1999, 72:209-253
6. Lowe JB: Glycosylation, immunity, and autoimmunity. Cell 2001, 104:809-812
7. Vestweber D, Blanks JE: Mechanisms that regulate the function of the selectins and their ligands. Physiol Rev 1999, 79:181-213
8. Palframan RT, Jung S, Cheng CY, Weninger W, Luo Y, Dorf M, Littman DR, Rollins BJ, Zweerink H, Rot A, von Andrian UH: Inflammatory chemokine transport and presentation in HEV: a remote control mechanism for monocyte recruitment to lymph nodes in inflamed tissues. J Exp Med 2001, 194:1361-1373
9. Reiss Y, Proudfoot AE, Power CA, Campbell JJ, Butcher EC: CC chemokine receptor (CCR)4 and the CCR10 ligand cutaneous T cell-attracting chemokine (CTACK) in lymphocyte trafficking to inflamed skin. J Exp Med 2001, 194:1541-1547
10. a, putative ligands for L-selectin, on peripheral lymph node high endothelial venules. Am J Pathol 1992, 141:1259-1264
11. Varki A: Selectin ligands: will the real ones please stand up? J Clin Invest 1997, 99:158-162
12. Hemmerich S, Rosen SD: Carbohydrate sulfotransferases in lymphocyte homing. Glycobiology 2000, 10:849-856
13. Satomaa T, Renkonen O, Helin J, Kirveskari J, Mäkitie A, Renkonen R: O-glycans on human high endothelial CD34 putatively participating in L-setectin recognition. Blood 2002, 99:2603-2611
14. Turunen J, Majuri M, Seppo A, Tiisala S, Paavonen T, Miyasaka M, Lemström K, Penttilä L, Renkonen O, Renkonen R: De novo expression of endothelial sialyl Lewis a and sialyl Lewis x during cardiac transplant rejection. Superior capacity of a tetravalent sLex-oligosaccharide in inhibiting L-selectin-dependent lymphocyte adhesion. J Exp Med 1995, 182:1133-1142
15. Renkonen O, Toppila S, Penttilä L, Salminen H, Helin J, Maaheimo H, Costello C, Turunen J, Renkonen R: Enzyme-assisted synthesis of a tetravalent sialyl Lewis x glycan, derived from a linear polylactosamine. Glycobiology 1997, 7:453-461
16. Duijvestijn AM, Horst E, Pals ST, Rouse BN, Steere AC, Picker LJ, Meijer CJLM, Butcher EC: High endothelial differentiation in human lymphoid and inflammatory tissues defined by monoclonal antibody HECA-452. Am J Pathol 1988, 130:147-155
17. Streeter PR, Rouse BTR, Butcher EC: Immunohistological and functional characterization of a vascular addressin involved in lymphocyte homing into peripheral lymph nodes. J Cell Biol 1988, 107:1853-1862
18. Ohmori K, Takada A, Ohwaki I, Takahashi N, Furukawa Y, Maeda M, Kiso M, Hasegawa A, Kannagi M, Kannagi R: A distinct type of sialyl Lewis X antigen defined by a novel monoclonal antibody is selectively expressed on helper memory T cells. Blood 1993, 82:2797-2805
19. Michie SA, Streeter PR, Bolt PA, Butcher EC, Picker LJ: The human peripheral lymph node vascular addressin. An inducible endothelial antigen involved in lymphocyte homing. Am J Pathol 1993, 143:1688-1698
20. Sassetti C, Tangemann K, Singer M, Kershaw D, Rosen S: Identification of podocalyxin-like protein as a high endothelial venule ligand for L-selectin: parallels to CD34. J Exp Med 1998, 187:1965-1975
21. Jalkanen S, Saari S, Kalimo H, Lammintausta K, Vainio E, Leino R, Duijvestijn A, Kalimo K: Lymphocyte migration into the skin: the role of lymphocyte homing receptor (CD44) and endothelial cell antigen (HECA-452). J Invest Dermatol 1990, 94:786-792
22. Toppila S, Lauronen J, Mattila P, Turunen J, Penttilä L, Paavonen T, Renkonen O, Renkonen R: L-selectin ligands in rat high endothelium. Multivalent sialyl Lewis x glycans are high affinity inhibitors of lymphocyte adhesion. Eur J Immunol 1997, 27:1360-1365
23. Toppila S, Renkonen R, Penttilä L, Natunen J, Salminen H, Helin J, Maaheimo H, Renkonen O: Enzymatic synthesis of α3′ sialylated and multiply α3fucosylated biantennary polylactosamines. A bivalent sialyl diLex-saccharide inhibited lymphocyte endothelial adhesion organ selectively. Eur J Biochem 1999, 261:208-215
24. Cotran R, Kumar V, Collins T: Pathologic Basis of Disease, ed 6. Philadelphia, WB Saunders Co., 1999
25. Bistrup A, Bhakta S, Lee JK, Belov YY, Gunn MD, Zuo FR, Huang CC, Kannagi R, Rosen SD, Hemmerich S: Sulfotransferases of two specificities function in the reconstitution of high endothelial cell ligands for L-selectin. J Cell Biol 1999, 145:899-910
26. Hiraoka N, Petryniak B, Nakayama J, Tsuboi S, Suzuki M, Yeh JC, Izawa D, Tanaka T, Miyasaka M, Lowe JB, Fukuda M: A novel, high endothelial venule-specific sulfotransferase expresses 6-sulfo sialyl Lewis(x), an L-selectin ligand displayed by CD34. Immunity 1999, 11:79-89
27. Hemmerich S, Bistrup A, Singer M, van Zante A, Lee J, Tsay D, Peters M, Carminati J, Brennan T, Carver-Moore K, Leviten M, Fuentes M, Ruddle N, Rosen S: Sulfation of L-selectin ligands by an HEV-restricted sulfotransferase regulates lymphocyte homing to lymph nodes. Immunity 2001, 15:237-247
28. Yeh J-C, Hiraoka N, Petryniak B, Nakayama J, Ellies LG, Rabuka D, Hindgaul O, Marth JD, Lowe JB, Fukuda M: Novel sulfated lymphocyte homing receptors and their control by a core 1 extension β1,3-N-acetylglucosaminyltransferase. Cell 2001, 105:957-969
29. Jimi T, Wakayama Y, Murahashi M, Inoue M, Shibuya S, Yamashita S, Misugi N, Kobayashi T: Expression of selectin families and their ligand sialyl Lewis X in the muscles of inflammatory myopathies: an immunohistochemical study. Intern Med 1999, 38:632-635
30. Lechleitner S, Kunstfeld R, Messeritsch-Fanta C, Wolff K, Petzelbauer P: Peripheral lymph node addressins are expressed on skin endothelial cells. J Invest Dermatol 1999, 113:410-414
31. Koivunen E, Arap W, Valtanen H, Rainisalo A, Medina OP, Heikkila P, Kantor C, Gahmberg CG, Salo T, Konttinen YT, Sorsa T, Ruoslahti E, Pasqualini R: Tumor targeting with a selective gelatinase inhibitor. Nature Biotechnol 1999, 17:768-774
32. Pasqualini R, Koivunen E, Kain R, Lahdenranta J, Sakamoto M, Stryhn A, Ashmun RA, Shapiro LH, Arap W, Ruoslahti E: Aminopeptidase N is a receptor for tumor-homing peptides and a target for inhibiting angiogenesis. Cancer Res 2000, 60:722-727
33. Ruoslahti E: Targeting tumor vasculature with homing peptides from phage display. Semin Cancer Biol 2000, 10:435-442
34. Ruoslahti E, Rajotte D: An address system in the vasculature of normal tissues and tumors. Annu Rev Immunol 2000, 18:813-827
35. Niemela R, Natunen J, Majuri ML, Maaheimo H, Helin J, Lowe JB, Renkonen O, Renkonen R: Complementary acceptor and site specificities of Fuc-TIV and Fuc-TVII allow effective biosynthesis of sialyl-TriLex and related polylactosamines present on glycoprotein counterreceptors of selectins. J Biol Chem 1998, 273:4021-4026
36. Roos C, Kolmer M, Mattila P, Renkonen R: Composition of Drosophila melanogaster proteome involved in fucosylated glycan metabolism. J Biol Chem 2002, 277:3168-3175
37. Tedder TF, Steeber DA, Pizcueta P: L-selectin-deficient mice have impaired leukocyte recruitment into inflammatory sites. J Exp Med 1995, 181:2259-2264
38. Maly P, Thall AD, Petryniak B, Rogers CE, Smith PL, Marks RM, Kelly RJ, Gersten KM, Cheng G, Saunders TL, Camper SA, Camphausen RT, Sullivan FX, Isogai Y, Hindsgaul O, von Andrian UH, Lowe JB: The α(1,3)fucosyltransferase Fuc-TVII controls leukocyte trafficking through an essential role in L-, E-, and P-selectin ligand biosynthesis. Cell 1996, 86:643-653
39. Homeister JW, Thall A, Petryniak B, Maly P, Rogers CE, Smith PL, Kelle RJ, Gersten KM, Askari SW, Cheng G, Smithson G, Marks RM, Misra AK, Hindsgaul O, von Andrian UH, Lowe JB: The α(1,3)fucosyltransferase FucT-IV and FucT-VII exert collaborative control over selectin-dependent leukocyte recruitment and lymphocyte homing. Immunity 2001, 15:115-126